Sort
21,281 grants matching “influenza”
Dynamics and Evolution of Immune Responses to Influenza Viruses
$1,631,454Rustom Noshir Antia · Emory University · U19 · FY2015 · AI
Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients
$1,631,325Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2025 · AI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses
$1,630,948Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Sex and Age Differences in Immunity to Influenza (SADII)
$1,630,087Sabra L Klein · Johns Hopkins University · U54 · FY2019 · AG
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
$1,629,815Francois J Villinger · University Of Louisiana At Lafayette · U19 · FY2023 · AI
Therapeutic Fully Human Monoclonal Antibodies against Vaccina Virus and Smallpox
$1,628,843Shane P Crotty · La Jolla Institute For Immunology · U01 · FY2011 · AI
Vaccine and Treatment Evaluation Unit at Saint Louis University
$1,627,722Daniel F. Hoft · Saint Louis University · UM1 · FY2020 · AI
Annual Estimates of Influenza Vaccine Effectiveness: Davidson County, TN
$1,627,597Marie R Griffin · Vanderbilt University · U18 · FY2009 · IP
Advanced Bioaerosols Technology Core
$1,627,452Don L Devoe · Univ Of Maryland, College Park · U19 · FY2024 · AI
MOUSE MODELS FOR UNDERSTANDING HOST RESPONES TO INTRACELLULAR PATHOGENS
$1,627,294Ellen A Robey · University Of California Berkeley · P01 · FY2010 · AI
Novel Chemical and Immunological Approaches to Influenza Therapy
$1,627,220Michael B Oldstone · Scripps Research Institute, The · U01 · FY2009 · AI
High-throughput, single-molecule sequence analysis of virus populations in vivo
$1,625,595Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Analysis of Host-Pathogen Interactions
$1,625,123Ronald Germain · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,624,315Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH
$1,624,291Bruxanne El-Kammash · University Of Chicago · N01 · FY2025 · AI
Rapid Estimation of Influenza Vaccine Effectiveness in a Wisconsin Population Coh
$1,623,642Edward Belongia · Marshfield Clinic Research Foundation · U18 · FY2009 · IP
Development of drugs that target the M2 proton channel from the influenza A Virus
$1,623,145William F Degrado · University Of Pennsylvania · U01 · FY2010 · AI
A deep longitudinal analysis of next generation influenza vaccines in older adults
$1,622,607Duygu Ucar · Jackson Laboratory · U01 · FY2022 · AI
AvanceIII 700MHz NMR spectrometer with cryogenic probe
$1,620,000James J Chou · Harvard Medical School · S10 · FY2010 · RR
Modeling Immunity for Biodefense
$1,619,351Icahn School Of Medicine At Mount Sinai · N01 · FY2010 · AI
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)
$1,618,435Fernando D Martinez · University Of Arizona · UH3 · FY2025 · HL
T CELL MEMORY TO PATHOGENS: GENERATION AND FUNCTION
$1,618,318Trudeau Institute, Inc. · P01 · FY2003 · AI
SCOR IN PATHOBIOLOGY OF LUNG DEVELOPMENT
$1,617,467University Of North Carolina Chapel Hill · P50 · FY2000 · HL
Modeling affinity maturation at molecular resolution
$1,616,696Thomas B Kepler · Boston University Medical Campus · U19 · FY2015 · AI
Production of an NP-ISS conjugate vaccine to combat pandemic influenza.
$1,616,687Gary A Van Nest · Dynavax Technologies Corporation · U01 · FY2008 · AI